These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Modulation of aberrant splicing in human RNA diseases by chemical compounds. Kataoka N Hum Genet; 2017 Sep; 136(9):1237-1245. PubMed ID: 28364159 [TBL] [Abstract][Full Text] [Related]
34. Antisense oligonucleotides and other genetic therapies made simple. Rossor AM; Reilly MM; Sleigh JN Pract Neurol; 2018 Apr; 18(2):126-131. PubMed ID: 29455156 [TBL] [Abstract][Full Text] [Related]
35. RNA-based therapies for genodermatoses. Bornert O; Peking P; Bremer J; Koller U; van den Akker PC; Aartsma-Rus A; Pasmooij AM; Murauer EM; Nyström A Exp Dermatol; 2017 Jan; 26(1):3-10. PubMed ID: 27376675 [TBL] [Abstract][Full Text] [Related]
36. Modulation of alternative splicing with chemical compounds in new therapeutics for human diseases. Ohe K; Hagiwara M ACS Chem Biol; 2015 Apr; 10(4):914-24. PubMed ID: 25560473 [TBL] [Abstract][Full Text] [Related]